Endovascular repair

血管内修复术
  • 文章类型: Journal Article
    目的:胸主动脉腔内修复术(TEVAR)后的呼吸不良事件(RAEs)特征仍然不明确,因为缺乏全面的研究来确定容易发生这些并发症的个体。这项研究旨在确定发病率,相关因素,TEVAR后RAE的结果。
    方法:我们确定了2010年至2023年接受TEVAR隔离至0-5区的非创伤性病变的血管质量倡议患者。在确定术后RAE的发生率后,我们评估了基线特征,病理学,程序细节,术后并发症按呼吸道并发症状态分层:无,只有肺炎,只有再插管,或者两者兼而有之。然后,我们使用多变量改进的Poisson回归检查了与术后RAE发展独立相关的术前和术中变量。Kaplan-Meier分析和Cox比例风险回归模型用于确定术后RAE和5年生存率之间的关联,并在单独的模型中调整术前变量和其他非呼吸道术后并发症。
    结果:在10,708名患者中,8.3%有任何RAE(仅肺炎:2.1%,仅再插管:4.8%,两者:1.4%)。有任何RAE的患者更有可能出现主动脉夹层(任何呼吸并发症:46%vs无呼吸并发症:35%;p<.001),并且有症状(58%vs48%;p<.001)。TEVAR后发展RAE与男性相关(aRR:1.19[95%CI:1.01-1.41];p=0.037),肥胖(1.31[1.07-1.61];p=0.009),病态肥胖(1.68[1.20-2.32];p=0.002),肾功能不全(eGFR30-45:1.45[1.15-1.82];p=0.002;eGFR<30/血液透析:1.7[1.37-2.11];p<0.001),贫血(1.31[1.09-1.58];p=0.003),主动脉直径>65mm(1.54[1.25-1.89];p<0.001),主动脉弓(1.23[1.03-1.48];p=0.025)或升主动脉(1.61[1.19-2.14];p=0.002)的近端疾病,急性主动脉夹层(2.13[1.72-2.63];p<0.001),破裂的表现(3.07[2.43-3.87];p<0.001),同一天手术胸科治疗(1.51[1.25-1.82];p<0.001),COPD在家庭氧气(1.58[1.08-2.25];p=0.014),有限的自我护理或卧床状态(2.12[1.45-3.03];p<0.001),术中输血(1.88[1.47-2.40];p<0.001)。术后发生RAE的患者30天死亡率(27%vs4%;p<.001)和5年死亡率高于无呼吸道并发症的患者(46%vs20%;p<0.001)。在术前和术后变量调整后,术后发生任何RAE的患者的5年死亡率更高(aHR:1.8[1.6,2.1];p<.001),仅术后肺炎(1.4[1.0,1.8];p=.046),仅再插管(2.2[1.8,2.6];p<.001)或两者(1.5[1.1,2.0];p=.008)。
    结论:TEVAR后的RAE很常见,更可能发生在男性肥胖患者中,肾功能不全,贫血,COPD对家庭氧气,急性主动脉夹层,破裂的演示文稿,同一天外科胸科治疗,接受术中输血的人,与5年死亡率增加2倍相关,而与其他术后并发症的发生无关.在评估TEVAR程序的风险和收益时考虑到这些因素,随着实施定制的术后护理,可能会改善临床结果。
    OBJECTIVE: Respiratory adverse events (RAEs) after thoracic endovascular aortic repair (TEVAR) remain poorly characterized due to the lack of comprehensive studies that identify individuals prone to these complications. This study aims to determine the incidence, factors associated with, and outcomes of RAEs after TEVAR.
    METHODS: We identified Vascular Quality Initiative patients undergoing TEVAR isolated to zones 0-5 from 2010 to 2023 for non-traumatic pathologies. After determining the incidence of post-operative RAEs, we assessed baseline characteristics, pathology, procedural details, and postoperative complications stratified by respiratory complication status: none, pneumonia only, reintubation only, or both. We then examined pre- and intra-operative variables independently associated with the development of postoperative RAEs using multivariable modified Poisson regression. Kaplan-Meier analysis and Cox proportional hazards regression model were used to determine associations between postoperative RAEs and 5-year survival adjusting for preoperative variables and other non-respiratory post-operative complications in a separate model.
    RESULTS: Of 10,708 patients, 8.3% had any RAE (pneumonia only: 2.1%, reintubation only: 4.8%, both: 1.4%). Patients with any RAE were more likely to present with aortic dissection (any respiratory complication: 46% vs no respiratory complication: 35%; p<.001), and be symptomatic (58% vs 48%;p<.001). Developing RAEs post-TEVAR was associated with male sex (aRR: 1.19 [95% CI: 1.01-1.41]; p=0.037), obesity (1.31[1.07-1.61]; p=0.009), morbid obesity (1.68[1.20-2.32]; p=0.002), renal dysfunction (eGFR 30-45: 1.45[1.15-1.82]; p=0.002; eGFR <30/hemodialysis: 1.7[1.37-2.11]; p<0.001), anemia (1.31[1.09-1.58]; p=0.003), aortic diameter >65mm (1.54[1.25-1.89]; p<0.001), proximal disease in the aortic arch (1.23[1.03-1.48]; p=0.025) or ascending aorta (1.61[1.19-2.14]; p=0.002), acute aortic dissection (2.13[1.72-2.63]; p<0.001), ruptured presentation (3.07[2.43-3.87]; p<0.001), same-day surgical thoracic branch treatment (1.51[1.25-1.82]; p<0.001), COPD on home oxygen (1.58[1.08-2.25]; p=0.014), limited self-care or bed-bound status (2.12[1.45-3.03]; p<0.001), and intraoperative transfusion (1.88[1.47-2.40]; p<0.001). Patients who developed post-operative RAEs had higher 30-day mortality (27% vs 4%; p<.001) and 5-year mortality than patients without respiratory complications (46% vs 20%; p<0.001). After adjusting for pre-operative and post-operative variables, 5-year mortality was higher in patients who developed any post-operative RAE (aHR: 1.8[1.6, 2.1]; p<.001), post-operative pneumonia only (1.4[1.0, 1.8];p=.046), reintubation only (2.2[1.8, 2.6]; p<.001) or both (1.5[1.1, 2.0]; p=.008).
    CONCLUSIONS: RAEs after TEVAR are common, more likely to occur in male patients with obesity, renal dysfunction, anemia, COPD on home oxygen, acute aortic dissection, ruptured presentation, same-day surgical thoracic branch treatment, who received intra-operative transfusion, and are associated with a two-fold increase in 5-year mortality regardless of the development of other post-operative complications. Considering these factors in assessing risks and benefits of TEVAR procedures, along with implementing customized post-operative care, can potentially improve clinical outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    尽管在急性B型主动脉夹层(TBAD)中有确定的高风险特征,它的管理是可变的。这项研究的特点是复杂的,简单,和高风险TBAD,除了他们的管理和结果,以深入了解这些高风险特征的实际意义和现实世界实践在管理TBAD。对62例患者进行了回顾性分析。患者人口统计学,管理,结果用皮尔逊χ2检验进行表征和评估,费希尔的精确检验,或方差分析(ANOVA)。在32个高风险TBAD中,66%(n=21)接受血管内修复,31%(n=10)接受医学管理,3%(n=1)接受了混合(开放和血管内)修复。难治性高血压和疼痛(52%,n=11)是接受血管内修复的高危TBAD患者中最常见的高危特征。最大主动脉直径>40mm(67%,n=6)是接受医疗管理的患者中最常见的高风险特征。高危TBAD中所有治疗组最普遍的高危特征是主动脉直径>40mm(n=16;50%)。术后不良结局在高风险和复杂组中最高,内漏是最常见的不良结局(高风险12.9%,复杂13.6%)。在62名患者中,47%(n=26)自入院以来进行了随访,平均随访时间为69±166天。高危特征在高危TBAD管理中的意义尚不清楚。这种单中心管理急性TBAD的经验揭示了可能特定于该疾病过程的随访不足的现实。这凸显了需要更多的努力来评估治疗后的长期结果。
    Although there are established high-risk features in acute type B aortic dissection (TBAD), its management is variable. This study characterizes complicated, uncomplicated, and high-risk TBAD in addition to their management and outcomes to gain insight into the actual significance of these high-risk features and the reality of real-world practice in managing TBAD. A retrospective review of 62 patients was conducted. Patient demographics, management, and outcomes were characterized and evaluated with Pearson\'s χ2 test, Fisher\'s exact test, or analysis of variance. Of the 32 high-risk TBADs, 66% (n = 21) received endovascular repair, 31% (n = 10) were medically managed, and 3% (n = 1) received hybrid (open and endovascular) repair. Refractory hypertension and pain (52%, n = 11) were the most common high-risk features in patients with high-risk TBAD who received endovascular repair. A maximum aortic diameter of >40 mm (67%, n = 6) was the most common high-risk feature in patients who received medical management. The most prevalent high-risk feature for all treatment groups in the high-risk TBADs was an aortic diameter of >40 mm (n = 16; 50%). Adverse postoperative outcomes were highest in the high-risk and complicated groups with endoleak as the most common adverse outcome (high-risk 12.9%, complicated 13.6%). Of the 62 patients, 47% (n = 26) had follow-up since their admission with an average follow-up time of 69 ± 166 days. The significance of high-risk features in the management of high-risk TBAD remains unclear. This single-center experience with managing acute TBAD reveals the reality of inadequate follow-up that may be specific to this disease process. This highlights a need to direct more efforts to assess long-term outcomes after treatment.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    教学要点:主动脉髂动脉瘤破裂,并发髂动静脉瘘,是罕见的,但有可能致命的结果,需要及时诊断和适当的治疗。
    Teaching point: A ruptured aorto-iliac aneurysm, complicated by an iliac arteriovenous fistula, is rare but has a possibly fatal outcome and requires prompt diagnosis and appropriate treatment.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    我们报告了一例65岁的男性患者,该患者被认为不适合进行开放性手术,并接受了医生改良的开窗内移植物治疗有症状的穿透性溃疡的0区血管内修复术。对胸部支架移植物进行了改良,为无名动脉和左颈总动脉创造了大开窗,对左锁骨下动脉和左椎动脉进行第二次小开窗术,有一个共同的起源。未将桥接支架用于左锁骨下动脉以避免覆盖左椎动脉。术后进展顺利,在术后计算机断层扫描血管造影中没有发现泄漏或其他并发症。尽管需要更好地评估长期耐久性,我们的经验表明,对于不适合患者的主动脉弓病变的紧急治疗,医师改良的开窗内移植物是一种可行的选择,并在短期内提供令人满意的结果.
    We report the case of a 65-year-old male patient who was deemed unfit for open surgery and underwent zone 0 endovascular repair with a physician-modified fenestrated endograft for a symptomatic penetrating ulcer. A thoracic stent graft was modified creating a large fenestration for the innominate artery and the left common carotid artery, and a second small fenestration for the left subclavian artery and the left vertebral artery, which had a common origin. No bridging stent was used for the left subclavian artery to avoid coverage of the left vertebral artery. The postoperative course was uneventful, and no leaks nor other complications were detected on postoperative computed tomography angiography. Although long-term durability needs to be better assessed, our experience suggests that physician-modified fenestrated endografts are a feasible option for the emergent treatment of aortic arch lesions in unfit patients and provide satisfactory results in the short term.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:本研究的目的是比较后路手术修复the动脉动脉瘤(PAAs)和血管内排除,分析多中心回顾性研究中的早期和五年结局。
    方法:在2010年1月至2023年12月之间,对37个中心接受后路开放修复或血管内修复的所有连续无症状PAA的回顾性维护数据集进行了调查。动脉瘤长度≤60mm被认为是唯一的纳入标准。共纳入605例患者;440PAA(72.7%)通过后路(开放组)治疗,其余165PAA(27.3%)使用覆膜支架治疗(Endo组)。连续数据表示为具有四分位数范围的中位数。评估并比较30天的结果。在跟进时,主要结果是免于再干预,二级通畅,和无截肢生存。次要结果是生存率和原发通畅性。使用对数秩检验比较估计的五年结果。
    结果:在30天,在主要发病率方面没有发现差异,死亡率,移植物闭塞,或重新干预。开放组3例(0.7%)出现神经损伤。总体中位随访时间为32.1个月。在五年的随访中,开放组的再干预自由度更高(82.2%vs.68.4%;p=.021)。继发性通畅性无差异(开放组90.7%vs.endo组85.2%;p=.25)或无截肢生存率(开放组99.0%vs.endo组98.4%;p=.73)。后路入路与更好的生存结果相关(84.4%vs.79.4%;p=.050),和初级通畅性(79.8%vs.63.8%;p=0.012)。
    结论:通过后入路或腔内隔绝术选择性修复≤60mm的PAA后,早期和长期结果似乎相当。对于那些接受开放手术的人来说,神经损伤可能是一种罕见但潜在的并发症。血管内修复与更多的再干预相关。
    OBJECTIVE: The aim of this study was compare elective surgical repair of popliteal artery aneurysms (PAAs) via a posterior approach vs. endovascular exclusion, analysing early and five year outcomes in a multicentre retrospective study.
    METHODS: Between January 2010 and December 2023, a retrospectively maintained dataset of all consecutive asymptomatic PAAs that underwent open repair with posterior approach or endovascular repair in 37 centres was investigated. An aneurysm length of ≤ 60 mm was considered the only inclusion criterion. A total of 605 patients were included; 440 PAAs (72.7%) were treated via a posterior approach (open group) and the remaining 165 PAAs (27.3%) were treated using covered stents (Endo group). Continuous data were expressed as median with interquartile range. Thirty day outcomes were assessed and compared. At follow up, primary outcomes were freedom from re-intervention, secondary patency, and amputation free survival. Secondary outcomes were survival and primary patency. Estimated five year outcomes were compared using log rank test.
    RESULTS: At 30 days, no differences were found in major morbidity, mortality, graft occlusion, or re-interventions. Three patients (0.7%) in the open group experienced nerve injury. The overall median duration of follow up was 32.1 months. At five year follow up, freedom from re-intervention was higher in the open group (82.2% vs. 68.4%; p = .021). No differences were observed in secondary patency (open group 90.7% vs. endo group 85.2%; p = .25) or amputation free survival (open group 99.0% vs. endo group 98.4%; p = .73). A posterior approach was associated with better survival outcomes (84.4% vs. 79.4%; p = .050), and primary patency (79.8% vs. 63.8%; p = .012).
    CONCLUSIONS: Early and long term outcomes following elective repair of PAAs measuring ≤ 60 mm via a posterior approach or endovascular exclusion seem comparable. Nerve injury might be a rare but potential complication for those undergoing open surgery. Endovascular repair is associated with more re-interventions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:青少年创伤患者锁骨下动脉损伤(SAI)和髂动脉损伤(IAI)的处理由于其复杂的解剖位置而提出了相当大的挑战。我们研究的目的是确定创伤SAI和IAI患者的损伤机制和修复类型与预后之间的关系。
    方法:在对2017-2020年美国外科医生学会创伤质量改善计划数据库的回顾性分析中,包括接受血管内或开放修复的SAI和IAI青少年(<18岁)患者。根据机制(钝性与穿透性)和修复类型(血管内[E]与开放[O])对患者进行分层并进行比较。衡量的结果是死亡率和主要并发症。进行多变量逻辑回归分析。
    结果:超过4年,170名儿科患者被确认,其中73人(43%)患有SAI,97人(57%)患有IAI。平均年龄为15岁,男性占79%。总的来说,39%是血管内管理。两组的中位损伤严重程度评分相当(E:23对O:25,P=0.278)。对于钝性损伤患者(n=60),修复类型与主要并发症无关(E:39%对O:33%,P=0.694)也没有死亡率(E:2.6%对O:4.8%,P=0.651)。对于穿透性损伤的患者(n=110),血管内修复术的发病率明显降低(19%对41%,P=0.034)和死亡率(3.7%对21%,P=0.041)。在多变量逻辑回归中,血管内修复术被确定为与死亡率降低相关的唯一可改变的危险因素(调整比值比:0.201,95%置信区间[0.14-0.76],P=0.038)。
    结论:难以进入的血管损伤导致显著的发病率和死亡率。发现血管内修复是唯一与穿透伤患者死亡率降低相关的可改变因素。而钝性损伤患者的修复类型与死亡率无关。
    BACKGROUND: Management of subclavian artery injuries (SAI) and iliac artery injuries (IAI) in adolescent trauma patients poses a considerable challenge due to their complex anatomical locations. The aim of our study was to determine the association between the injury mechanism and type of repair with the outcomes of patients with traumatic SAI and IAI.
    METHODS: In this retrospective analysis of the American College of Surgeons Trauma Quality Improvement Program database2017-2020, adolescent (<18 y) patients with SAI and IAI undergoing either endovascular or open repair were included. Patients were stratified by mechanism (blunt versus penetrating) and type of repair (endovascular [E] versus open [O]) and compared. Outcomes measured were mortality and major complications. Multivariable logistic regression analyses were performed.
    RESULTS: Over 4 y, 170 pediatric patients were identified, of which 73 (43%) sustained an SAI and 97 (57%) had IAI. The mean age was 15 and 79% were male. Overall, 39% were managed endovascularly. Both groups had comparable median injury severity score (E: 23 versus O: 25, P = 0.278). For patients with blunt injury (n = 60), the type of repair was neither associated with major complications (E: 39% versus O: 33%, P = 0.694) nor mortality (E: 2.6% versus O: 4.8%, P = 0.651). For patients with penetrating injuries (n = 110), the endovascular repair had significantly lower morbidity (19% versus 41%, P = 0.034) and mortality (3.7% versus 21%, P = 0.041). On multivariable logistic regression, endovascular repair was identified as the only modifiable risk factor associated with reduced mortality (adjusted odds ratio: 0.201, 95% confidence interval [0.14-0.76], P = 0.038).
    CONCLUSIONS: Difficult-to-access vascular injuries result in significant morbidity and mortality. Endovascular repair was found to be the only modifiable factor associated with decreased mortality of patients with penetrating injury, whereas the type of repair was not associated with mortality in those with blunt injury.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:我们旨在分析1998年至2017年芬兰和瑞典腹主动脉瘤(AAA)的开放(OAR)或腔内修复(EVAR)后的患者预后。完整和破裂的AAAs(rAAAs)均包括在分析中。方法:分析了芬兰和瑞典国家登记处的患者水平数据,完整和破裂AAA修复的配对手术与死亡率数据(死亡日期)。全因死亡率是主要终点。来自这两个国家的匿名患者数据进行汇总,包括总共32,324次操作。破裂和完整的AAAs分别考虑。总的来说,对9619个完整的AAAs和1470个rAAAs进行了EVAR,而OAR是对13,241个完整的AAA和7994个rAAA进行的。病人的年龄,性别和手术日期作为人口统计信息.Cox回归和Kaplan-Meier分析用于评估AAA或rAAA治疗后的长期(10年)生存率。Kaplan-Meier分析在三个不同年龄段(<65岁,65-79岁和≥80岁)。结果:考虑到所有年龄组,1-,EVAR后3年和10年Kaplan-Meier生存率为93.4%,80.5%和35.3%,分别,完整的AAA修复和67.2%,55.9%和22.2%,分别,用于RAAA修复。对于完整AAAs的OAR,1-,3年和10年Kaplan-Meier生存率为92.1%,84.8%和48.7%,分别。rAAAs的OAR率分别为55.4%,49.3%和24.6%。在Cox回归分析中,最近一年的手术与生存率的提高有关,年龄和年龄对完整和破裂的AAA修复的生存率均产生负面影响。如果患者在手术后的前90天存活下来,对于<65岁的患者(一般人群:18.0岁),完整的AAA修复后的生存期为13.5年,≥80岁的人为7.3岁(一般人群:7.9岁)。经过rAAA修复,<65岁患者的平均生存期为13.1年,≥80岁患者的平均生存期为5.5年,分别。结论:80岁或以上接受完整AAA治疗的患者的长期生存率接近普通人群,只要他们在手术中幸存下来。相反,对于年龄小于65岁的患者,其长期生存率明显较差.随着时间的推移,AAA患者的长期生存率有所改善。对于接受完整AAA修复的年轻患者,开放手术仍然是安全有效的选择。我们的结果支持ESVS指南推荐的EVAR作为rAAA患者的一线治疗。
    Objective: We aimed to analyse patient outcomes following open (OAR) or endovascular repair (EVAR) of an abdominal aortic aneurysm (AAA) in Finland and Sweden from 1998 to 2017. Both intact and ruptured AAAs (rAAAs) were included in the analysis. Methods: Patient-level data from national registries in Finland and Sweden were analysed, pairing operations for intact and ruptured AAA repair with mortality data (date of death). All-cause mortality was the primary endpoint. Anonymized patient data from both countries were pooled, comprising a total of 32,324 operations. Ruptured and intact AAAs were considered separately. In total, EVAR was performed on 9619 intact AAAs and 1470 rAAAs, while OAR was performed on 13,241 intact AAAs and 7994 rAAAs. The patient\'s age, sex and the date of operation were obtained as demographic information. Cox regression and Kaplan-Meier analyses were used to evaluate long-term (10-year) survival after the treatment of AAA or rAAA with either modality. Kaplan-Meier analysis was performed in three different age groups (<65 years, 65-79 years and ≥80 years). Results: Considering all age groups together, the 1-, 3- and 10-year Kaplan-Meier survival rates after EVAR were 93.4%, 80.5% and 35.3%, respectively, for intact AAA repair and 67.2%, 55.9% and 22.2%, respectively, for rAAA repair. For OAR of intact AAAs, the 1-, 3- and 10-year Kaplan-Meier survival rates were 92.1%, 84.8% and 48.7%, respectively. The respective rates for OAR of rAAAs were 55.4%, 49.3% and 24.6%. In a Cox regression analysis, a more recent year of operation was associated with improved survival, and older age affected survival negatively for both intact and ruptured AAA repair. If patients survived the first 90 days after the operation, the survival after intact AAA repair was 13.5 years for those <65 years (general population: 18.0 years), and 7.3 years for those ≥80 years (general population: 7.9 years). After rAAA repair, the mean survival was 13.1 years for patients <65 years and 5.5 years for patients ≥80 years, respectively. Conclusions: The long-term survival of patients undergoing intact AAA treatment at the age of 80 or older is close to that of the general population, provided they survive the operation. Conversely, for patients younger than 65, the long-term survival is markedly worse. The long-term survival of AAA patients has improved over time. Open surgery is still a safe and effective option for young patients undergoing intact AAA repair. Our results support the ESVS guidelines recommendation of EVAR being the first-line treatment for patients with rAAA.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:本系列病例的目的是探讨双开窗内科医生改良内移植物(PMEGs)对远端吻合动脉瘤患者在升主动脉开放修复或近端弓置换后的疗效。
    方法:回顾了2017年至2023年所有连续的开放性升主动脉手术后远端吻合动脉瘤的患者,这些患者使用自制的双开窗支架进行了主动脉弓修复。研究终点包括技术成功,30天,和死亡率的长期随访分析,发病率,重新干预。
    结果:10例患者在升主动脉开放手术后接受双开窗PMEGs治疗吻合动脉瘤。其中,9人为男性,平均年龄58岁。9名患者最初接受急性夹层治疗,两个有机械主动脉瓣。开放手术与假性动脉瘤治疗之间的平均时间为4.15年。技术成功100%。近端着陆区始终位于0区,所有内移植物均通过股骨入路展开。早期结果显示一个内漏(1a型),通过及时重新干预成功治疗。术后早期无死亡或中风发生。在长期随访期间(平均时间35个月),没有发生需要干预的内漏,没有支架骨折或迁移的报告。没有患者死于主动脉相关原因。
    结论:对于开放手术后的远端吻合动脉瘤,采用双开窗的PMEG进行主动脉弓修复是可行的,并且对于不适合进行重做手术的患者是一种有希望的替代方法。
    BACKGROUND: The objective of this case series is to investigate the outcomes of double-fenestrated physician-modified endografts (PMEGs) in patients with distal anastomotic aneurysms after open repair of the ascending aorta or proximal arch replacement.
    METHODS: All consecutive patients with a distal anastomotic aneurysm after open ascending aorta surgery who underwent aortic arch repair with a homemade double-fenestrated stent-graft from 2017 to 2023 were reviewed. Study endpoints included technical success, 30-day, and long-term follow up analysis of mortality, morbidity, and reinterventions.
    RESULTS: 10 patients were treated with double-fenestrated PMEGs for anastomotic aneurysms after open surgery of the ascending aorta. Of these, 9 were male with a mean age of 58 years. Nine patients were initially treated for acute dissection, and 2 had mechanical aortic valves. The mean time between open surgery and the treatment of the pseudoaneurysm was 4.15 years. Technical success was 100%. The proximal landing zone was consistently in zone 0, and all endografts were deployed via femoral access. Early outcomes revealed one endoleak (type 1a), which was successfully treated by prompt reintervention. No deaths or strokes occurred during the early postoperative period. During long-term follow up (mean time 35 months), no endoleaks requiring intervention occurred, and there were no reports of stent fractures or migrations. No patient died from an aortic-related cause.
    CONCLUSIONS: Aortic arch repair with double-fenestrated PMEGs for distal anastomotic aneurysms after open surgery is feasible and represents a promising alternative in patients ineligible for redo surgery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    这项单中心研究旨在评估接受联合单一Perclose(雅培,雅培公园,Illinois)Suture-MediatedClosureDevice+singleAngio-SealVIP8F(Terumo,东京,日本)并将结果与标准DualPerclose技术进行比较。材料和方法:2022年11月至2023年11月连续择期pEVAR患者,股骨入路健康,导管鞘≤20French(F)外径,包括在内。投币随机化确定是否使用了单个Perclose设备+单个Angio-SealVIP8F(混合技术)或标准双Perclose设备(DualPerclose)的组合。在混合技术中,在12点放置一个Perclose装置;去除鞘后放置一个Angio-SealVIP8F。DualPerclose遵循标准程序。主要终点包括立即止血,鞘管直径差异,访问转换率,技术上的成功,和成本分析。
    该研究纳入60名符合纳入标准的pEVAR患者(中位年龄=78岁,四分位距[IQR]=72-85岁)。在14例(24%)中,仅研究了1个股骨入路。有106个pEVAR访问,混合技术组58(54.7%),双重Perclose组48(45.3%)。两组在术前特征和鞘管直径方面均表现出均匀性(HybridTechnology-16FvsDualPerclose-18F;p=0.202)。混合技术组的即时止血率为100%,而DualPerclose组的止血率为87.5%(p=0.006)。手术通路转换是不必要的。技术成功100%,DualPerclose术后所有6例股出血病例血管内消退,使用额外的设备。成本分析显示,混合技术组的中位成本为330欧元(IQR=0),而DualPerclose组的中位成本为384欧元(IQR=360-456)(p<0.001)。30天死亡率为3%,在两个脆弱的病人中,没有通路相关的并发症。多变量分析确定DualPerclose通路(比值比[OR]=35.6;95%置信区间[CI]=18.3-36.8;p<0.001)和肥胖(OR=19.7;95%CI=1.4-23.9.5;p<0.001)是立即止血失败的独立危险因素。中位随访时间为134天(IQR=41-227),用1例混合技术(2%)成功地在62天后注射凝血酶治疗了小的股骨假性动脉瘤。
    在选定患者的pEVAR期间,选择性混合技术与单个Perclose装置+单个血管密封VIP8F的组合似乎不劣于标准的DualPerclose程序。它显示了减少立即止血失败和成本的积极趋势。两种程序均获得了技术上的成功,并避免了手术进入转换。
    结论:本研究引入了一种新的选择性混合技术,该技术将单个Perclose装置与单个Angio-SealVIP8Fr相结合,用于经皮血管内腹主动脉介入治疗。混合技术的结果显示100%的技术成功和有效的立即止血,同时成本低于标准的双重Perclose程序。两种手术都不需要手术转换。尽管是单中心研究,它证明了这种混合技术有意应用于微创的潜在好处。肥胖和双重Perclose技术被确定为止血失败的独立危险因素。重申混合技术程序的有效性以及与标准程序的非劣效性。
    UNASSIGNED: This single-center study aimed to assess patients who underwent intentional percutaneous endovascular aortic aneurysm repair (pEVAR) with Hybrid Technique combining a single Perclose (Abbott, Abbott Park, Illinois) Suture-Mediated Closure Device + single Angio-Seal VIP 8F (Terumo, Tokyo, Japan) and compare outcomes with the standard Dual Perclose technique. Materials and Methods: Consecutive elective pEVAR patients treated from November 2022 to November 2023, with healthy femoral accesses and introducer sheaths ≤20 French (F) outer diameter, were included. Coin-toss randomization determined whether a combination of single Perclose Device + single Angio-Seal VIP 8F (Hybrid Technique) or the standard double Perclose Devices (Dual Perclose) was used. In Hybrid Technique, a single Perclose device was positioned at 12 o\'clock; a single Angio-Seal VIP 8F was placed after sheaths removal. Dual Perclose followed standard procedure. Primary endpoints included immediate hemostasis, sheath diameter differences, access conversion rate, technical success, and cost analysis.
    UNASSIGNED: The study involved 60 pEVAR patients (median age=78, interquartile range [IQR]=72-85 years) within the inclusion criteria. In 14 (24%) cases, only 1 femoral access was studied. There were 106 pEVAR accesses, with 58 (54.7%) in the Hybrid Technique group and 48 (45.3%) in the Dual Perclose group. Both groups exhibited homogeneity in pre-operative characteristics and sheath diameter (Hybrid Technique-16F vs Dual Perclose-18F; p=0.202). Immediate hemostasis was achieved in 100% of the Hybrid Technique group vs 87.5% for the Dual Perclose group (p=0.006). Surgical access conversion was unnecessary. Technical success was 100%, with all 6 femoral bleeding cases after Dual Perclose resolved endovascularly, using additional devices. Cost analysis showed a median cost of 330 euros (IQR=0) for the Hybrid Technique group vs 384 euros (IQR=360-456) for the Dual Perclose group (p<0.001). Thirty-day mortality was 3%, in 2 fragile patients, without access-related complications. Multivariate analysis identified Dual Perclose access (odds ratio [OR]=35.6; 95% confidence interval [CI]=18.3-36.8; p<0.001) and obesity (OR=19.7; 95% CI=1.4-23.9.5; p<0.001) as independent risk factors for immediate hemostasis failure. Median follow-up was 134 days (IQR=41-227), with 1 Hybrid Technique case (2%) successfully treated with thrombin injection for a small femoral pseudoaneurysm after 62 days.
    UNASSIGNED: The elective Hybrid Technique with combination of single Perclose Device + single Angio-Seal VIP 8F during pEVAR in selected patients appears to be non-inferior to the standard Dual Perclose procedure. It demonstrates a positive trend in reducing immediate hemostasis failure and costs. Both procedures achieved technical success and avoiding surgical access conversions.
    CONCLUSIONS: This study introduces a novel elective hybrid technique combining a single Perclose device with a single Angio-Seal VIP 8Fr for percutaneous endovascular abdominal aortic interventions. Results for hybrid technique showed 100% technical success and efficient immediate hemostasis, while costing less than standard dual Perclose procedure. Both procedures did not require surgical conversions. Despite being a single-center study, it demonstrates potential benefits of the intentional application of this hybrid technique towards minimally invasiveness. Obesity and dual Perclose technique were identified as independent risk factors for hemostasis failure, reaffirming the hybrid technique procedure\'s efficacy as well as and non-inferiority to standard procedure.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号